[ad_1]
Because the path of science depends on accumulation, the promising medical milestones of 2018 require further testing, particularly in the first-stage mice.
In the case of effective treatments, academic institutions must adopt their plans to produce a drug at an appropriate price, which will ensure treatment for millions of patients around the world.
1. Vaccine against cancer
In January, researchers at Stanford University announced the development of a vaccine capable of eliminating cancerous tumors.
According to The Times Insider, a vaccine has been tested on cancer mice capable of eliminating cancerous tumors in the animal. If successful, treating the critical illness will be easier and more effective.
Cancer chemotherapy currently affects the immune system and many patients experience serious side effects.
"There is no limit to the types of tumors that this vaccine can treat," said Ronald Levy, professor and research author.
2. Extraordinary facial culture
In 2018, French surgeons performed a "medical miracle" by performing a second facial transplant for the same patient.
The patient, who was not named, had a facial transplant 7 years ago, but his body refused a strong and surprising transplant.
The patient, aged forty or so years, spent two months in the faceless hospital and the doctors plunged him into coma after removing the "first face" until 39 that a suitable donor be found for the second face.
The surgery lasted a whole day and doctors would not be able to tell if the operation worked or not, a few weeks ago.
According to Telegraph, facial implants are very rare, with forty or so operations performed to date. Patients should continue to take drugs that inhibit the immune system so that their body does not reject "intruders".
One of the side effects of these medications is that they make patients predisposed to infections and cancer.
3-medicine protects against heart attacks
Biotech Amarin announced last September that it has developed a drug called Vacepa, which can reduce the risk of heart attack by 25%. Every year, 610,000 people die each year from heart attacks in the United States.
It is sold on prescription and is offered to people who follow a low fat diet such as high cholesterol.
The FDA approved this drug in 2015, but this year it has been shown to reduce some of the harmful fats in the body.
4 – Bushra for migraine patients
In the absence of any effective and comprehensive treatment against migraines called "sister", the FDA approved, in May 2018, the drug "Aimoving" and this treatment gave an injection a month to disable some of the molecules responsible for the pain caused by the disease.
The drug was tested three times. Patients who received injections said that their condition had improved significantly and that the number of episodes of the disease had been less than before.
In another development, doctors said that a Brazilian woman was born after undergoing a uterine donor transplant in the first successful case of her kind.
The condition, published in the Lancet medical journal, included the delivery of veins from the donor's uterus to the recipient's veins, as well as the delivery of arteries, ligaments, and badl channels.
The birth follows the failure of 10 previous cases, in which uterine donors were transferred to live births in the United States, the Czech Republic and Turkey.
The importance of this process has been noted, as it could offer infertile women access to more potential donors.
Because diabetics need to pay attention to the level of blood glucose, the Institute of Science and Technology of Ulsan has developed contact lenses that can help people with the disease.
The prestigious institution said in an official statement that these lenses were based on human tears to monitor the glucose level.
These contact lenses consist of nanostructures, which are very thin not to affect human vision, but these lenses have been tested on the rabbit only.
5- Depression sprays
In May, Johnson & Johnson announced a vaccine model that could be used to treat depression by relying on the drug called ketamine for decades.
The researchers conducted an experiment involving 236 people with severe clbadic depression, followed by 236 people on the impact.
Experience has shown that those who used a nasal spray at the same time as traditional medications felt a clear improvement in just 4 weeks, unlike those who did not use ketamine vaporizer.
Source link
